VEGFA and diabetic retinopathy: Syringaresinol reduces oxidative stress by activating the Nrf2 antioxidant pathway, improving retinal microvascular damage by inhibiting HIF-1/VEGF and thus easing the early progression of diabetic retinopathy (Liu et al., 2024).